shadow_tr

 

 

Inventors

 

 

Intellectual Property

 

 

Available for

  • Exclusive Licensing
  • Non-exclusive Licensing
  • Scientific Collaboration

  

Confidential Disclosure Agreement

 

 

For more information, please contact:

     Justin Levy
     Licensing Associate
     504-988-6962
     jlevy5@tulane.edu

 

Novel Aptamers Effective Against Tumor Growth and Inflammation (printable)

 

Tulane University is actively seeking commercial entities to further develop and commercialize novel compounds which effectively remove thrombin and trypsin from the human blood stream, thereby inhibiting tumor growth and inflammation.

 

 

Applications

  • Provides effective treatment of:
    • Metastatic tumors
    • Inflammatory conditions

  • Potential use in a diagnostic where a single molecule can serve as both the protein binding and signaling agent


 

Advantages

  • Reduce both thrombin and trypsin in the blood stream
  • Are not degradable by normal protease activity
  • Can be regulated once in the patient
  • Potentially easy to manufacture with low toxicity



Development Status

This technology has been tested extensively in vitro, with results strongly supporting the efficacy of the compounds. Laboratory work is ongoing to produce more effective species of these compounds.

Tulane University, New Orleans, LA 70118 504-865-5000 website@tulane.edu